Artykuły w czasopismach na temat „Macrophage inhibitory cytokine - 1”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Macrophage inhibitory cytokine - 1”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Huh, Sung Jin, Chin-Ying Chung, Arati Sharma i Gavin P. Robertson. "Macrophage Inhibitory Cytokine-1 Regulates Melanoma Vascular Development". American Journal of Pathology 176, nr 6 (czerwiec 2010): 2948–57. http://dx.doi.org/10.2353/ajpath.2010.090963.
Pełny tekst źródłaLu, Chunxia, P. Anil Kumar, Yong Fan, Mark A. Sperling i Ram K. Menon. "A Novel Effect of Growth Hormone on Macrophage Modulates Macrophage-Dependent Adipocyte Differentiation". Endocrinology 151, nr 5 (25.02.2010): 2189–99. http://dx.doi.org/10.1210/en.2009-1194.
Pełny tekst źródłaSingla, Reetu D., Jing Wang i Dinender K. Singla. "Regulation of Notch 1 signaling in THP-1 cells enhances M2 macrophage differentiation". American Journal of Physiology-Heart and Circulatory Physiology 307, nr 11 (1.12.2014): H1634—H1642. http://dx.doi.org/10.1152/ajpheart.00896.2013.
Pełny tekst źródłaHuang, Mingguo, Shintaro Narita, Takamitsu Inoue, Norihiko Tsuchiya, Shigeru Satoh, Hiroshi Nanjo, Takehiko Sasaki i Tomonori Habuchi. "Diet-induced macrophage inhibitory cytokine 1 promotes prostate cancer progression". Endocrine-Related Cancer 21, nr 1 (luty 2014): 39–50. http://dx.doi.org/10.1530/erc-13-0227.
Pełny tekst źródłaYamashita, Toshiharu, Akihiro Yoneta i Tokimasa Hida. "Macrophage Inhibitory Cytokine-1: A New Player in Melanoma Development". Journal of Investigative Dermatology 129, nr 2 (luty 2009): 262–64. http://dx.doi.org/10.1038/jid.2008.366.
Pełny tekst źródłaBorsini, Alessandra, Maria Grazia Di Benedetto, Juliette Giacobbe i Carmine M. Pariante. "Pro- and Anti-Inflammatory Properties of Interleukin in Vitro: Relevance for Major Depression and Human Hippocampal Neurogenesis". International Journal of Neuropsychopharmacology 23, nr 11 (29.07.2020): 738–50. http://dx.doi.org/10.1093/ijnp/pyaa055.
Pełny tekst źródłaAndreone, Teresa, Gordon P. Meares, Katherine J. Hughes, Polly A. Hansen i John A. Corbett. "Cytokine-mediated β-cell damage in PARP-1-deficient islets". American Journal of Physiology-Endocrinology and Metabolism 303, nr 2 (15.07.2012): E172—E179. http://dx.doi.org/10.1152/ajpendo.00055.2012.
Pełny tekst źródłaCalandra, T., J. Bernhagen, R. A. Mitchell i R. Bucala. "The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor." Journal of Experimental Medicine 179, nr 6 (1.06.1994): 1895–902. http://dx.doi.org/10.1084/jem.179.6.1895.
Pełny tekst źródłaHayes, V. M. "Macrophage Inhibitory Cytokine-1 H6D Polymorphism, Prostate Cancer Risk, and Survival". Cancer Epidemiology Biomarkers & Prevention 15, nr 6 (1.06.2006): 1223–25. http://dx.doi.org/10.1158/1055-9965.epi-06-0063.
Pełny tekst źródłaBrown, D. A., F. Lindmark, P. Stattin, K. Balter, H. O. Adami, S. L. Zheng, J. Xu i in. "Macrophage Inhibitory Cytokine 1: A New Prognostic Marker in Prostate Cancer". Clinical Cancer Research 15, nr 21 (20.10.2009): 6658–64. http://dx.doi.org/10.1158/1078-0432.ccr-08-3126.
Pełny tekst źródłaBaek, Kyoung Eun, Suk Ran Yoon, Jong-Tae Kim, Kwang Soo Kim, Seong Ho Kang, Young Yang, Jong-Seok Lim i in. "Upregulation and secretion of macrophage inhibitory cytokine-1 (MIC-1) in gastric cancers". Clinica Chimica Acta 401, nr 1-2 (marzec 2009): 128–33. http://dx.doi.org/10.1016/j.cca.2008.12.008.
Pełny tekst źródłaBaer, Mark, Allan Dillner, Richard C. Schwartz, Constance Sedon, Sergei Nedospasov i Peter F. Johnson. "Tumor Necrosis Factor Alpha Transcription in Macrophages Is Attenuated by an Autocrine Factor That Preferentially Induces NF-κB p50". Molecular and Cellular Biology 18, nr 10 (1.10.1998): 5678–89. http://dx.doi.org/10.1128/mcb.18.10.5678.
Pełny tekst źródłaKhaled, Yazan S., Eyad Elkord i Basil J. Ammori. "Macrophage Inhibitory Cytokine-1: A review of its pleiotropic actions in cancer". Cancer Biomarkers 11, nr 5 (29.11.2012): 183–90. http://dx.doi.org/10.3233/cbm-2012-00287.
Pełny tekst źródłaLindmark, F., S. L. Zheng, F. Wiklund, J. Bensen, K. A. Balter, B. Chang, M. Hedelin i in. "H6D Polymorphism in Macrophage-Inhibitory Cytokine-1 Gene Associated With Prostate Cancer". JNCI Journal of the National Cancer Institute 96, nr 16 (17.08.2004): 1248–54. http://dx.doi.org/10.1093/jnci/djh227.
Pełny tekst źródłaCrabtree, Traves D., Long Jin, Daniel P. Raymond, Shawn J. Pelletier, C. Webster Houlgrave, Thomas G. Gleason, Timothy L. Pruett i Robert G. Sawyer. "Preexposure of Murine Macrophages to CpG Oligonucleotide Results in a Biphasic Tumor Necrosis Factor Alpha Response to Subsequent Lipopolysaccharide Challenge". Infection and Immunity 69, nr 4 (1.04.2001): 2123–29. http://dx.doi.org/10.1128/iai.69.4.2123-2129.2001.
Pełny tekst źródłaTong, Stephen, Budi Marjono, David A. Brown, Sheila Mulvey, Samuel N. Breit, Ursula Manuelpillai i Euan M. Wallace. "Serum concentrations of macrophage inhibitory cytokine 1 (MIC 1) as a predictor of miscarriage". Lancet 363, nr 9403 (styczeń 2004): 129–30. http://dx.doi.org/10.1016/s0140-6736(03)15265-8.
Pełny tekst źródłaBauskin, Asne R., David A. Brown, Tamara Kuffner, Heiko Johnen, X. Wei Luo, Mark Hunter i Samuel N. Breit. "Role of Macrophage Inhibitory Cytokine-1 in Tumorigenesis and Diagnosis of Cancer: Figure 1." Cancer Research 66, nr 10 (15.05.2006): 4983–86. http://dx.doi.org/10.1158/0008-5472.can-05-4067.
Pełny tekst źródłaBreit, S. N., J. J. Carrero, V. W. W. Tsai, N. Yagoutifam, W. Luo, T. Kuffner, A. R. Bauskin i in. "Macrophage inhibitory cytokine-1 (MIC-1/GDF15) and mortality in end-stage renal disease". Nephrology Dialysis Transplantation 27, nr 1 (22.09.2011): 70–75. http://dx.doi.org/10.1093/ndt/gfr575.
Pełny tekst źródłaWiklund, Fredrik E., Anna M. Bennet, Patrik K. E. Magnusson, Ulrika K. Eriksson, Fredrik Lindmark, Liyun Wu, Nasreen Yaghoutyfam i in. "Macrophage inhibitory cytokine-1 (MIC-1/GDF15): a new marker of all-cause mortality". Aging Cell 9, nr 6 (21.10.2010): 1057–64. http://dx.doi.org/10.1111/j.1474-9726.2010.00629.x.
Pełny tekst źródłaKaran, Dev, Jeffrey Holzbeierlein i J. Brantley Thrasher. "Macrophage Inhibitory Cytokine-1: Possible Bridge Molecule of Inflammation and Prostate Cancer: Figure 1." Cancer Research 69, nr 1 (31.12.2008): 2–5. http://dx.doi.org/10.1158/0008-5472.can-08-1230.
Pełny tekst źródłaStejskal, David, Michal Karpíšek, Viera Humeňanská, Bořek Lačňák i Marek Švesták. "Macrophage-inhibitory cytokine-1 (mic-1) in differential diagnosis of dyspnea—A pilot study". Clinical Biochemistry 42, nr 13-14 (wrzesień 2009): 1347–51. http://dx.doi.org/10.1016/j.clinbiochem.2009.03.022.
Pełny tekst źródłaHoshino, Yoshihiko, Koh Nakata, Satomi Hoshino, Yoshihiro Honda, Doris B. Tse, Tatsuo Shioda, William N. Rom i Michael Weiden. "Maximal HIV-1 Replication in Alveolar Macrophages during Tuberculosis Requires both Lymphocyte Contact and Cytokines". Journal of Experimental Medicine 195, nr 4 (18.02.2002): 495–505. http://dx.doi.org/10.1084/jem.20011614.
Pełny tekst źródłaLemay, Serge, Tatiana V. Lebedeva i Ajay K. Singh. "Inhibition of Cytokine Gene Expression by Sodium Salicylate in a Macrophage Cell Line through an NF-κB-Independent Mechanism". Clinical Diagnostic Laboratory Immunology 6, nr 4 (1.07.1999): 567–72. http://dx.doi.org/10.1128/cdli.6.4.567-572.1999.
Pełny tekst źródłaMoore, A. G., D. A. Brown, W. D. Fairlie, A. R. Bauskin, P. K. Brown, M. L. C. Munier, P. K. Russell, L. A. Salamonsen, E. M. Wallace i S. N. Breit. "The Transforming Growth Factor-β Superfamily Cytokine Macrophage Inhibitory Cytokine-1 Is Present in High Concentrations in the Serum of Pregnant Women1". Journal of Clinical Endocrinology & Metabolism 85, nr 12 (1.12.2000): 4781–88. http://dx.doi.org/10.1210/jcem.85.12.7007.
Pełny tekst źródłaMarjono, B., U. Manuelpillai, E. Dimitriadis, L. Salamonsen, S. Breit i E. Wallace. "270.Macrophage inhibitory cytokine-1 at the maternal - fetal interface in early pregnancy". Reproduction, Fertility and Development 16, nr 9 (2004): 270. http://dx.doi.org/10.1071/srb04abs270.
Pełny tekst źródłaMüller, Ruth, Jörg Klug, Miriam Rodewald i Andreas Meinhardt. "Macrophage migration inhibitory factor suppresses transforming growth factor-β2 secretion in cultured rat testicular peritubular cells". Reproduction, Fertility and Development 17, nr 4 (2005): 435. http://dx.doi.org/10.1071/rd04061.
Pełny tekst źródłaMehta, Raaj S., Navya Bezawada, Mingyang Song, Kana Wu, Xabier Garcia-de-Albeniz, Charles Fuchs, Shuji Ogino, Edward Giovannucci i Andrew T. Chan. "648 Circulating Macrophage Inhibitory Cytokine-1 (MIC-1) Is Associated With Risk of Colorectal Cancer". Gastroenterology 144, nr 5 (maj 2013): S—115. http://dx.doi.org/10.1016/s0016-5085(13)60415-1.
Pełny tekst źródłaNakamura, T., A. Scorilas, C. Stephan, G. M. Yousef, G. Kristiansen, K. Jung i E. P. Diamandis. "Quantitative analysis of macrophage inhibitory cytokine-1 (MIC-1) gene expression in human prostatic tissues". British Journal of Cancer 88, nr 7 (kwiecień 2003): 1101–4. http://dx.doi.org/10.1038/sj.bjc.6600869.
Pełny tekst źródłaUnsicker, Klaus, Björn Spittau i Kerstin Krieglstein. "The multiple facets of the TGF-β family cytokine growth/differentiation factor-15/macrophage inhibitory cytokine-1". Cytokine & Growth Factor Reviews 24, nr 4 (sierpień 2013): 373–84. http://dx.doi.org/10.1016/j.cytogfr.2013.05.003.
Pełny tekst źródłaChong, Mark M. W., Donald Metcalf, Emma Jamieson, Warren S. Alexander i Thomas W. H. Kay. "Suppressor of cytokine signaling-1 in T cells and macrophages is critical for preventing lethal inflammation". Blood 106, nr 5 (1.09.2005): 1668–75. http://dx.doi.org/10.1182/blood-2004-08-3049.
Pełny tekst źródłaYadon, A., D. Ruelas, G. Min-Oo, J. Taylor i M. R. Warr. "AB0108 IRAK4 INHIBITION SUPPRESSES PROINFLAMMATORY CYTOKINE PRODUCTION FROM HUMAN MACROPHAGES STIMULATED WITH SYNOVIAL FLUID FROM RHEUMATOID ARTHRITIS PATIENTS". Annals of the Rheumatic Diseases 79, Suppl 1 (czerwiec 2020): 1353.2–1353. http://dx.doi.org/10.1136/annrheumdis-2020-eular.3793.
Pełny tekst źródłaKim, Do-Hoon, Ji-Young Lee, Young-Jin Kim, Hyun-Ju Kim i Wansu Park. "Rubi Fructus Water Extract Alleviates LPS-Stimulated Macrophage Activation via an ER Stress-Induced Calcium/CHOP Signaling Pathway". Nutrients 12, nr 11 (22.11.2020): 3577. http://dx.doi.org/10.3390/nu12113577.
Pełny tekst źródłaHines II, Murray E., Charles A. Baldwin, Eloise L. Styer, Gordon A. Hullinger i John R. Cole. "Effects of macrophage inhibitory factor-A3 (MIF-A3) on cytokine secretion and phagolysosome fusion in murine macrophages". Veterinary Microbiology 65, nr 1 (luty 1999): 47–60. http://dx.doi.org/10.1016/s0378-1135(98)00283-1.
Pełny tekst źródłaRenz, JF, i GF Kalf. "Role for interleukin-1 (IL-1) in benzene-induced hematotoxicity: inhibition of conversion of pre-IL-1 alpha to mature cytokine in murine macrophages by hydroquinone and prevention of benzene-induced hematotoxicity in mice by IL-1 alpha". Blood 78, nr 4 (15.08.1991): 938–44. http://dx.doi.org/10.1182/blood.v78.4.938.938.
Pełny tekst źródłaRenz, JF, i GF Kalf. "Role for interleukin-1 (IL-1) in benzene-induced hematotoxicity: inhibition of conversion of pre-IL-1 alpha to mature cytokine in murine macrophages by hydroquinone and prevention of benzene-induced hematotoxicity in mice by IL-1 alpha". Blood 78, nr 4 (15.08.1991): 938–44. http://dx.doi.org/10.1182/blood.v78.4.938.bloodjournal784938.
Pełny tekst źródłaAlbertoni, Michele, Phillip H. Shaw, Michimasa Nozaki, Sophie Godard, Mirna Tenan, Marie-France Hamou, Douglas W. Fairlie i in. "Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1". Oncogene 21, nr 27 (czerwiec 2002): 4212–19. http://dx.doi.org/10.1038/sj.onc.1205610.
Pełny tekst źródłaCrilly, Anne, Susan E. Robertson, James H. Reilly, J. Alastair Gracie, Wen-Qi Lai, Bernard P. Leung, Paul F. Life i Iain B. McInnes. "Phosphodiesterase 4 (PDE4) regulation of proinflammatory cytokine and chemokine release from rheumatoid synovial membrane". Annals of the Rheumatic Diseases 70, nr 6 (21.02.2011): 1130–37. http://dx.doi.org/10.1136/ard.2010.134825.
Pełny tekst źródłaLeyva-Illades, Dinorah, Rama P. Cherla, Moo-Seung Lee i Vernon L. Tesh. "Regulation of Cytokine and Chemokine Expression by the Ribotoxic Stress Response Elicited by Shiga Toxin Type 1 in Human Macrophage-Like THP-1 Cells". Infection and Immunity 80, nr 6 (19.03.2012): 2109–20. http://dx.doi.org/10.1128/iai.06025-11.
Pełny tekst źródłaGolkar, L., X. Ding, M. B. Ujiki, R. M. Salabat, D. J. Bentrem, M. S. Talamonti, R. H. Bell i T. E. Adrian. "Resveratrol inhibits pancreatic cancer cell proliferation through transcriptional induction of macrophage inhibitory cytokine-1 (MIC-1)". Journal of Surgical Research 130, nr 2 (luty 2006): 195. http://dx.doi.org/10.1016/j.jss.2005.11.094.
Pełny tekst źródłaSian, Lee Jian, Malina Jasamai, Nor Syafinaz Yaakob i Norsyahida Mohd Fauzi. "Synthetic chalcone derivatives inhibit cytokine secretion via inhibition of ERK and JNK pathways in human U937 macrophage". Tropical Journal of Pharmaceutical Research 18, nr 4 (18.05.2021): 753–59. http://dx.doi.org/10.4314/tjpr.v18i4.11.
Pełny tekst źródłaStojanovic, Ivana, Danijela Maksimovic-Ivanic, Y. Al-Abed, F. Nicoletti i Stanislava Stosic-Grujicic. "Control of the of the final stage of immune-mediated diabetes by ISO-1, an antagonist of macrophage migration inhibitory factor". Archives of Biological Sciences 60, nr 3 (2008): 389–401. http://dx.doi.org/10.2298/abs0803389s.
Pełny tekst źródłaLu, Hong, Yongyu Bai, Lianfeng Wu, Weilong Hong, Yong Liang, Bicheng Chen i Yongheng Bai. "Inhibition of Macrophage Migration Inhibitory Factor Protects against Inflammation and Matrix Deposition in Kidney Tissues after Injury". Mediators of Inflammation 2016 (2016): 1–12. http://dx.doi.org/10.1155/2016/2174682.
Pełny tekst źródłaDUBEY, SEEMA, PETER VANVELDHUIZEN, JEFFREY HOLZBEIERLEIN, OSSAMA TAWFIK, J. BRANTLEY THRASHER i DEV KARAN. "Inflammation-associated regulation of the macrophage inhibitory cytokine (MIC-1) gene in prostate cancer". Oncology Letters 3, nr 5 (6.03.2012): 1166–70. http://dx.doi.org/10.3892/ol.2012.635.
Pełny tekst źródłaGolkar, Laleh, Xian-Zhong Ding, Michael B. Ujiki, Mohammad R. Salabat, David L. Kelly, Denise Scholtens, Angela J. Fought i in. "Resveratrol Inhibits Pancreatic Cancer Cell Proliferation Through Transcriptional Induction of Macrophage Inhibitory Cytokine-1". Journal of Surgical Research 138, nr 2 (kwiecień 2007): 163–69. http://dx.doi.org/10.1016/j.jss.2006.05.037.
Pełny tekst źródłaKarczewska-Kupczewska, Monika, Irina Kowalska, Agnieszka Nikolajuk, Agnieszka Adamska, Elzbieta Otziomek, Maria Gorska i Marek Straczkowski. "Hyperinsulinemia acutely increases serum macrophage inhibitory cytokine-1 concentration in anorexia nervosa and obesity". Clinical Endocrinology 76, nr 1 (7.12.2011): 46–50. http://dx.doi.org/10.1111/j.1365-2265.2011.04139.x.
Pełny tekst źródłaDu, Zhong-Hong, Xiao-Ping Wei i Qi-Yuan Hui. "Role of macrophage inhibitory cytokine-1 in the development and progression of gastric cancer". World Chinese Journal of Digestology 17, nr 22 (2009): 2272. http://dx.doi.org/10.11569/wcjd.v17.i22.2272.
Pełny tekst źródłaBaumgart, Samuel, Deborah A. Barber, Hong Ping Zhang, Michelle Lee-Ng, Samuel Breit, David Brown i Mark Danta. "Macrophage Inhibitory Cytokine 1 (MIC1/GDF15) as a Novel Serum Biomarker of Colonic Neoplasia". Gastroenterology 152, nr 5 (kwiecień 2017): S1030. http://dx.doi.org/10.1016/s0016-5085(17)33483-2.
Pełny tekst źródłaDanta, M., D. A. Barber, H. P. Zhang, M. Lee-Ng, S. W. L. Baumgart, V. W. W. Tsai, Y. Husaini i in. "Macrophage inhibitory cytokine-1/growth differentiation factor-15 as a predictor of colonic neoplasia". Alimentary Pharmacology & Therapeutics 46, nr 3 (1.06.2017): 347–54. http://dx.doi.org/10.1111/apt.14156.
Pełny tekst źródłaKoopmann, Jens, Phillip Buckhaults, David A. Brown, Marianna L. Zahurak, Norihiro Sato, Noriyoshi Fukushima, Lori J. Sokoll i in. "Serum Macrophage Inhibitory Cytokine 1 as a Marker of Pancreatic and Other Periampullary Cancers". Clinical Cancer Research 10, nr 7 (1.04.2004): 2386–92. http://dx.doi.org/10.1158/1078-0432.ccr-03-0165.
Pełny tekst źródłaMimeault, Murielle, i Surinder K. Batra. "Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine-1 in cancer". Journal of Cellular Physiology 224, nr 3 (12.05.2010): 626–35. http://dx.doi.org/10.1002/jcp.22196.
Pełny tekst źródła